Gothenburg, Nov. 14, 2022 – Lucero AB has received the European Innovation Council’s (EIC) Transition grant to continue developing its 3D cell culture handling platform.
Lucero awarded 900 000 SEK Vinnova Innovative Startups Stage 2 grant to build on Stage 1 progress in preparation for an on-site pharmaceutical pilot project and Seed round funding.
Out of 934 applicants, Lucero was selected by Vinnova, Sweden’s Innovation Agency, as one of the recipients of the Innovative Startups Stage 1 grant. The grant is targeted towards early-stage startups that are based on innovative products and services and that show global growth potential. The money is meant to help startups develop their prototypes and business models, as well as create strategies to protect and commercialize their intellectual assets.
Lucero has been selected by SPIE, the international society for optics and photonics, as one of the semi-finalists in the Pre-Seed, Healthcare category of their Photonics West Startup Challenge. This is the second time in a row that Lucero has been selected to participate in the competition, which will be held digitally this year on May 26th.
We are proud to announce that Lucero’s co-founder, Falko Schmidt, has successfully defended his Ph.D. thesis and has earned his doctoral degree. We sat down to speak with him after the conclusion of this four-year journey:
Chalmers Ventures hosted their annual Accelerator Pitch event during the first week of November. The event showcases new additions to their Accelerator program with a friendly pitch competition. This year, the event was held digitally and the best pitch was decided by public vote.
The Lucero team would like to extend our warmest thanks to the Nordic Startup Awards team and to everyone who voted for us. It is such an honor to be chosen from a group of such strong companies. A big congratulations to the other Swedish nominees, Spermosens, Deversify, tendo, and Flow. As well as to the other national winners, Particle3D, CLEX Bio, SurgeryVision, and Controlant.
At the end of each of EIT’s programs, two participating companies are chosen to pitch at their Finals Day event. The event showcases the companies that have excelled in each program. This year, Lucero was selected alongside Lifelet Medical from the EIT Health Validation Lab.
Pitch Day 2020 (or week, rather) is underway! Seven promising startups from Chalmers Ventures’ Accelerator will showcase their companies digitally this year for a chance to win 50,000 SEK. The winner is decided based on public voting, so go in and take a look at these great companies and vote (we hope you choose Lucero)!
Lucero is pleased to announce that it has been included in this year’s AI Landscape project. The project is led by AI Sweden, Ignite Sweden, and the Research Institutes of Sweden (RISE) with the purpose of finding and supporting the best AI startups in Sweden that have the potential to accelerate and contribute to the use of AI applications in the country.